Sandeep Sahay VIEW CLINICAL PROFILE

Sandeep Sahay, MD, MSc, ATSF

Associate Professor of Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Description of Research

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Embolism

Interstitial Lung Diseases

Areas Of Expertise

Pulmonary fibrosis Pulmonary hypertension Pulmonary arterial hypertension chronic thromboembolic pulmonary hypertension
Education & Training

MD
Publications

Tyvaso DPI: Drug-device characteristics and patient clinical considerations
McEvoy, C, Argula, R, Sahay, S, Shapiro, S, Eagan, C, Hickey, AJ, Smutney, C, Dillon, C, Winkler, T, Davis, BN, Broderick, M & Burger, C 2023, , Pulmonary Pharmacology and Therapeutics, vol. 83, 102266, pp. 102266. https://doi.org/10.1016/j.pupt.2023.102266, https://doi.org/10.1016/j.pupt.2023.102266

Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output
Sahay, S, Lane, J, Sharpe, MG, Toth, D, Paul, D, Siuba, MT & Tonelli, AR 2023, , Annals of the American Thoracic Society, vol. 20, no. 12, pp. 1752-1759. https://doi.org/10.1513/AnnalsATS.202303-216OC

Tyvaso DPI: Drug-device characteristics and patient clinical considerations
McEvoy, C, Argula, R, Sahay, S, Shapiro, S, Eagan, C, Hickey, AJ, Smutney, C, Dillon, C, Winkler, T, Davis, BN, Broderick, M & Burger, C 2023, , Pulmonary Pharmacology and Therapeutics, vol. 83, 102266. https://doi.org/10.1016/j.pupt.2023.102266

Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output
Sahay, S, Lane, J, Sharpe, MG, Toth, D, Paul, D, Siuba, MT & Tonelli, AR 2023, , Annals of the American Thoracic Society, vol. 20, no. 12, pp. 1752-1759. https://doi.org/10.1513/AnnalsATS.202303-216OC

Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey
Rice, JL, Austin, ED, Mathai, SC & Sahay, S 2023, , CHEST. https://doi.org/10.1016/j.chest.2023.11.026

End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities
Ali, HJ & Sahay, S 2023, , Seminars in Respiratory and Critical Care Medicine, vol. 44, no. 6, pp. 866-876. https://doi.org/10.1055/s-0043-1770124

Management of pulmonary hypertension associated with valvular heart disease with angiotensin-receptor neprilysin inhibitor
Ali, HJR, Thomas, J, Sahay, S & Guha, A 2023, , Pulmonary Circulation, vol. 13, no. 4, e12303, pp. e12303. https://doi.org/10.1002/pul2.12303

Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group
Morland, K, Gerges, C, Elwing, J, Visovatti, SH, Weatherald, J, Gillmeyer, KR, Sahay, S, Mathai, SC, Boucly, A, Williams, PG, Harikrishnan, S, Minty, EP, Hobohm, L, Jose, A, Badagliacca, R, Lau, EMT, Jing, ZC, Vanderpool, RR, Fauvel, C, Leonidas Alves, J, Strange, G, Pulido, T, Qian, J, Li, M, Mercurio, V, Zelt, JGE, Moles, VM, Cirulis, MM, Nikkho, SM, Benza, RL & Elliott, CG 2023, , Pulmonary Circulation, vol. 13, no. 4, e12317, pp. e12317. https://doi.org/10.1002/pul2.12317, https://doi.org/10.1002/pul2.12317

Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group
Morland, K, Gerges, C, Elwing, J, Visovatti, SH, Weatherald, J, Gillmeyer, KR, Sahay, S, Mathai, SC, Boucly, A, Williams, PG, Harikrishnan, S, Minty, EP, Hobohm, L, Jose, A, Badagliacca, R, Lau, EMT, Jing, ZC, Vanderpool, RR, Fauvel, C, Leonidas Alves, J, Strange, G, Pulido, T, Qian, J, Li, M, Mercurio, V, Zelt, JGE, Moles, VM, Cirulis, MM, Nikkho, SM, Benza, RL & Elliott, CG 2023, , Pulmonary Circulation, vol. 13, no. 4, e12317. https://doi.org/10.1002/pul2.12317

Tobacco, Second-Hand Smoke and Cancer
Pinkaew, D, Dammad, T, Bitar, M, Sahay, S & Folz, RJ 2023, . in EH Bernicker (ed.), Environmental Oncology : Theory and Impact. Springer, pp. 119-145. https://doi.org/10.1007/978-3-031-33750-5_5

Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry
Lachant, D, Minkin, R, Swisher, J, Mogri, M, Zolty, R, Hwang, S, Seaman, S, Broderick, M & Sahay, S 2023, , Pulmonary Pharmacology and Therapeutics, vol. 82, 102232, pp. 102232. https://doi.org/10.1016/j.pupt.2023.102232

The cascade screening in heritable forms of pulmonary arterial hypertension
Varghese, NP, Padhye, AA, Magoulas, PL, Mallory, GB, Ruiz, FE & Sahay, S 2023, , Pulmonary Circulation, vol. 13, no. 3, e12259, pp. e12259. https://doi.org/10.1002/pul2.12259

The role of riociguat in combination therapies for pulmonary arterial hypertension
Rahaghi, FF, Trivieri, MG & Sahay, S 2023, , Respiratory Medicine, vol. 211, 107196, pp. 107196. https://doi.org/10.1016/j.rmed.2023.107196

Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models
Fadah, K, Cruz Rodriguez, JB, Alkhateeb, H, Mukherjee, D, Garcia, H, Schuller, D, Mohammad, KO, Sahay, S & Nickel, NP 2023, , Pulmonary Circulation, vol. 13, no. 2, e12209, pp. e12209. https://doi.org/10.1002/pul2.12209

Insulin-like growth factor binding protein-4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
Estrada, RA & Sahay, S 2023, , Pulmonary Circulation, vol. 13, no. 2, e12252, pp. e12252. https://doi.org/10.1002/pul2.12252

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
Nathan, SD, Deng, C, King, CS, DuBrock, HM, Elwing, J, Rajagopal, S, Rischard, F, Sahay, S, Broderick, M, Shen, E, Smith, P, Tapson, VF & Waxman, AB 2023, , CHEST, vol. 163, no. 2, pp. 398-406. https://doi.org/10.1016/j.chest.2022.09.007

Effects of COVID-19 pandemic on the management of pulmonary hypertension
Zhou, CY, Sahay, S, Shlobin, O, Soto, FJ, Mathai, SC, Melendres-Groves, L, Mullin, CJ, Levine, DJ, Kay, D, Highland, K, Bossone, E, Poms, A, Memon, H, Balasubramanian, V, Farmer, MJS, Rahaghi, F & Elwing, JM 2023, , Respiratory Medicine, vol. 206, 107061. https://doi.org/10.1016/j.rmed.2022.107061

Pulmonary hypertension due to high cardiac output
Qaiser, KN, Sahay, S & Tonelli, AR 2023, , Respiratory Medicine, vol. 206, 107034, pp. 107034. https://doi.org/10.1016/j.rmed.2022.107034

Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis
DeBerry, J, Rali, P, McDaniel, M, Kabrhel, C, Rosovsky, R, Melamed, R, Friedman, O, Elwing, JM, Balasubramanian, V, Sahay, S, Bossone, E, Farmer, MJS, Klein, AJP, Hamm, ME, Ross, CB & Rivera-Lebron, BN 2023, , Frontiers in Medicine, vol. 10, 1080342, pp. 1080342. https://doi.org/10.3389/fmed.2023.1080342

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
the INSPIRE study investigators 2022, , Pulmonary Circulation, vol. 12, no. 3, e12119, pp. e12119. https://doi.org/10.1002/pul2.12119

VIEW FULL PUBLICATIONS